한글목차

세계 혈액 관리 시스템 시장은 2024년에 152억 2,000만 달러로 평가되며, 2030년에는 235억 6,000만 달러에 달할 것으로 예상되며, 예측 기간 동안 7.53%의 CAGR로 성장할 것으로 예상됩니다.

이 시장은 외과 수술의 증가, 외상 및 만성질환의 발병률 증가, 효과적인 혈액 사용과 수혈의 안전성에 대한 강조로 인해 강력한 성장세를 보이고 있습니다. 전 세계 인구의 고령화, 심혈관질환 및 암 환자의 급증으로 인해 신뢰할 수 있는 혈액 관리 시스템에 대한 수요가 증가하고 있습니다. 의료 기관들은 혈액 낭비를 줄이고, 재고 관리를 개선하며, 수혈의 정확성을 보장하는 기술에 대한 투자를 늘리고 있습니다. 또한, 효율적인 혈액 사용을 촉진하기 위한 유리한 상환 정책과 정부의 노력은 시장 성장을 촉진하고 있습니다. 자동화, 디지털 추적 및 실시간 모니터링의 발전은 혈액 수집, 보관 및 투여 방법을 재구성하고 있으며, 이는 전 세계 의료 환경 전반에 걸쳐 수요를 더욱 촉진하고 있습니다.

시장 촉진요인

혈액 및 혈액제제 수요 확대

주요 시장 과제

높은 도입 비용과 유지보수 비용

주요 시장 동향

클라우드 기반 혈액 관리 솔루션 도입

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 혈액 관리 시스템 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율과 예측
  • 유형별(기증 관리 모듈, 수혈 서비스 모듈, 재고 관리, 기증 스케줄, 스크리닝과 검사, 보고와 분석, 통합과 상호운용성, 기타)
  • 최종사용자별(혈액은행, 병원, 외래 진료 센터, 기타)
  • 기업별(2024)
  • 지역별
• 시장 맵

제6장 북미의 혈액 관리 시스템 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 멕시코
  • 캐나다

제7장 유럽의 혈액 관리 시스템 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 프랑스
  • 독일
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 혈액 관리 시스템 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 한국
  • 일본
  • 호주

제9장 남미의 혈액 관리 시스템 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 혈액 관리 시스템 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 인수합병
• 제품 출시
• 최근 동향

제13장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 능력
• 고객의 능력
• 대체품의 위협

제14장 경쟁 구도

• Cerner Corporation
• Haemonetics Corporation
• Telvent GIT S.A.
• Terumo Corporation
• Fresenius SE & Co. KGaA
• Grifols, S.A.
• Baxter International Inc.
• Stryker Corporation
• Becton, Dickinson and Company
• Biolife Solutions, Inc.

제15장 전략적 제안

제16장 조사 회사 소개 및 면책사항

영문목차

The Global Blood Management System Market was valued at USD 15.22 Billion in 2024 and is projected to reach USD 23.56 Billion by 2030, growing at a CAGR of 7.53% during the forecast period. The market is experiencing strong growth driven by the increasing number of surgical procedures, rising incidence of trauma and chronic illnesses, and greater emphasis on effective blood usage and transfusion safety. With the aging global population and a surge in cardiovascular and cancer cases, demand for reliable blood management systems is on the rise. Healthcare institutions are increasingly investing in technologies that reduce blood wastage, improve inventory control, and ensure transfusion accuracy. Additionally, favorable reimbursement policies and government efforts aimed at promoting efficient blood use are enhancing market growth. Advancements in automation, digital tracking, and real-time monitoring are reshaping how blood is collected, stored, and administered, further fueling demand across global healthcare settings.

Key Market Drivers

Growing Demand for Blood and Blood Products

The surging demand for blood and related products continues to drive the growth of the global blood management system market. Medical treatments such as surgeries, cancer therapies, and organ transplants rely heavily on the availability of blood transfusions to enhance patient recovery. This increased need directly contributes to the adoption of advanced systems that enable efficient management of blood resources. For example, patients with sickle cell disease, which affects around 100,000 individuals in the United States, require lifelong blood transfusion support. Healthcare facilities are recognizing the importance of accurate tracking, storage, and usage of blood units, leading to greater adoption of blood management technologies to address growing demand and ensure optimal supply chain efficiency.

Key Market Challenges

High Implementation and Maintenance Costs

A significant challenge in the global blood management system market is the high cost associated with implementation and maintenance. The initial investment in acquiring sophisticated systems-including software, hardware, and infrastructure-can be substantial, often deterring smaller healthcare facilities or those in resource-constrained regions. Integration with existing hospital networks may require tailored solutions, increasing the overall expense. Additionally, these systems demand ongoing maintenance such as regular software updates, technical support, and calibration of advanced features like temperature monitoring and automated tracking. The need for specialized staff training and compliance with strict regulatory requirements further elevates operational costs, posing a barrier to broader market penetration.

Key Market Trends

Adoption of Cloud-Based Blood Management Solutions

The increasing adoption of cloud-based solutions is a transformative trend in the global blood management system market. Cloud platforms offer scalable, cost-effective alternatives to traditional on-premise systems, enabling seamless data storage, remote access, and enhanced collaboration among healthcare providers. This model reduces the need for expensive infrastructure while improving operational flexibility and data security. Cloud-based systems also support integration with Electronic Health Records (EHR), promoting real-time data sharing and improving transfusion accuracy and safety. This trend is especially advantageous for smaller facilities and institutions in emerging markets. As digital transformation becomes a strategic priority in healthcare, cloud adoption is expected to expand, facilitating more efficient and responsive blood supply chain management.

Key Market Players

• Cerner Corporation
• Haemonetics Corporation
• Telvent GIT S.A.
• Terumo Corporation
• Fresenius SE & Co. KGaA
• Grifols, S.A.
• Baxter International Inc.
• Stryker Corporation
• Becton, Dickinson and Company
• Biolife Solutions, Inc.

Report Scope

In this report, the Global Blood Management System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Management System Market, By Type:

• Donor Management Module
• Transfusion Service Module
• Inventory Management
• Donation Scheduling
• Screening & Testing
• Reporting & Analytics
• Integration & Interoperability
• Others

Blood Management System Market, By End User:

• Blood Banks
• Hospitals
• Ambulatory Care Centers
• Others

Blood Management System Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Management System Market.

Available Customizations

Global Blood Management System Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Blood Management System Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Donor Management Module, Transfusion Service Module, Inventory Management, Donation Scheduling, Screening & Testing, Reporting & Analytics, Integration & Interoperability, Others)
  • 5.2.2. By End User (Blood Banks, Hospitals, Ambulatory Care Centers, Others)
  • 5.2.3. By Company (2024)
  • 5.2.4. By Region
• 5.3. Market Map

6. North America Blood Management System Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Blood Management System Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By End User
  • 6.3.2. Mexico Blood Management System Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By End User
  • 6.3.3. Canada Blood Management System Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By End User

7. Europe Blood Management System Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Blood Management System Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By End User
  • 7.3.2. Germany Blood Management System Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By End User
  • 7.3.3. United Kingdom Blood Management System Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By End User
  • 7.3.4. Italy Blood Management System Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By End User
  • 7.3.5. Spain Blood Management System Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By End User

8. Asia-Pacific Blood Management System Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Blood Management System Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By End User
  • 8.3.2. India Blood Management System Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By End User
  • 8.3.3. South Korea Blood Management System Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By End User
  • 8.3.4. Japan Blood Management System Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By End User
  • 8.3.5. Australia Blood Management System Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By End User

9. South America Blood Management System Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Blood Management System Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By End User
  • 9.3.2. Argentina Blood Management System Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By End User
  • 9.3.3. Colombia Blood Management System Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By End User

10. Middle East and Africa Blood Management System Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Blood Management System Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By End User
  • 10.3.2. Saudi Arabia Blood Management System Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By End User
  • 10.3.3. UAE Blood Management System Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Cerner Corporation
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Haemonetics Corporation
• 14.3. Telvent GIT S.A.
• 14.4. Terumo Corporation
• 14.5. Fresenius SE & Co. KGaA
• 14.6. Grifols, S.A.
• 14.7. Baxter International Inc.
• 14.8. Stryker Corporation
• 14.9. Becton, Dickinson and Company
• 14.10. Biolife Solutions, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer